For the first time, a human islet-like cell cluster with immune avoidance has been developed and is expected to be used to treat type 1 diabetes.
Nature: How does Dantu blood type fight malaria? Studies have found that high-stress blood cells can resist parasite invasion.
New Cells: Fighting Acute New Coronary Infections These immune cells are more important than antibodies?
Cell: Uncovering the true face of Lushan, Li Lanxuan/Li Sai analyzed the complete molecular structure of the new coronavirus for the first time.
OrR reached 86% of patients with specific non-small cell lung cancer with positive clinical results for next-generation precision therapy.
First-line treatment of advanced renal cell carcinoma Innovative immuno combination therapy submitted regulatory applications.
Science: Super-powerful antibody mixture blocks new coronavirus from attaching to host cells.
Cell: Tsinghua University and Zhejiang University have teamed up to reveal the molecular structure of the new coronavirus.
CELL: Immunological study of multi-system inflammatory syndrome in children with new crowns.
Lancet Oncol: Navusan anti-new assisted immunochemotherapy greatly improves the prognostics of small cell lung cancer.
Overcoming EGFR mutation non-small cell lung cancer resistance First three total HER3 targeted ADC clinical results were positive.
CELL: Zika vaccination may have protective effect on infection with new coronavirus in elderly (ACTIVATE trial)
Corning Jerry KN046 treated non-small cell lung cancer Phase III clinically completed the first case of patients.
Non-small cell lung cancer advances in China in August 2020.
One Nature and one Cell paper revealed the mechanism of action of the protein LRRK2 associated with Parkinson's disease.
PLoS Pathog: The multiple sclerosis drug Fingommod blocks hiv infection and transmission in human immune cells.
Nature: Heavy! For the first time, a human islet-like cell cluster with immune avoidance has been
Cell: Single dose of ChAd vaccine protects the upper and lower respiratory tracts from SARS-CoV-2 infection.
treatment of extensive stage small cell lung cancer (ES-SCLC)!
And platinum medicine at the 2020 Cell Engager Summit to showcase the newly developed BCMA x CD3 dual-specific antibodies.